Europe DNA/RNA Sample Extraction and Isolation Research Report 2024: A $1.23 Billion Market by 2033, Driven by Rising Demand for Genomic Analysis in Research, Diagnostics, and Forensic App...
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Yahoo! Finance
and Isolation Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The Europe DNA/RNA sample extraction and isolation market was valued at $629.0 million in 2023 and is expected to reach $1,236.2 million by 2033, growing at a CAGR of 6.99% between 2023 and 2033. This expansion can be ascribed to rising demand for genetic analysis in research, clinical diagnostics, and forensic applications, as well as increased adoption of new technologies and disease prevalence. The market includes a variety of methods, reagents, instruments, and services for extracting and isolating high-quality nucleic acids from biological specimens. With rising demand for genomic analysis in research, clinical diagnostics, and forensic applications, as well as the adoption of new technologies and illness prevalence, the market is expanding rapidly. The Europe DNA/RNA sample extraction and isolation market includes a diverse set of technologies, reagents, in
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- Here's Why Investors Should Retain QIAGEN (QGEN) Stock Now [Yahoo! Finance]Yahoo! Finance
- QIAGEN's (QGEN) QCI Interpret Gets European IVDR Certification [Yahoo! Finance]Yahoo! Finance
- QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support [Yahoo! Finance]Yahoo! Finance
- QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision supportGlobeNewswire
- QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus [Yahoo! Finance]Yahoo! Finance
QGEN
Earnings
- 4/29/24 - Beat
QGEN
Analyst Actions
- 5/1/24 - Stifel
QGEN
Sec Filings
- 5/1/24 - Form 6-K
- 5/1/24 - Form 6-K
- 3/11/24 - Form 20-F
- QGEN's page on the SEC website